Literature DB >> 25219466

Apoptosis signal-regulating kinase 1 modulates the phenotype of α-synuclein transgenic mice.

Kang-Woo Lee1, Jong-Min Woo1, Joo-Young Im1, Eun S Park1, Liqiang He1, Hidenori Ichijo2, Eunsung Junn1, M Maral Mouradian3.   

Abstract

α-Synuclein is a key pathogenic protein in α-synucleinopathies including Parkinson's disease, and its overexpression and aggregation in model systems are associated with a neuroinflammatory response and increased oxidative stress. Apoptosis signal-regulating kinase 1 (ASK1) is activated upon stress signaling events such as oxidative stress and is a central player linking oxidative stress with neuroinflammation. Here, we demonstrate that overexpression of human α-synuclein activates ASK1 in both PC12 cells and in the brains of α-synuclein transgenic mice. Deleting ASK1 in mice mitigates the neuronal damage and neuroinflammation induced by α-synuclein and improves performance of the animals on the rotarod. ASK1 deletion does not impact the aggregation profile or phosphorylation state of α-synuclein in the mouse brain. These results collectively implicate ASK1 in the cascade of events triggered by α-synuclein overexpression, likely because of the inflammatory response and oxidative stress that lead to ASK1 activation. These conclusions raise the possibility that potent antioxidants and anti-inflammatory agents may ameliorate the phenotype of α-synucleinopathies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Neurodegeneration; Neuroinflammation; Neuroprotection; Oxidative stress; Parkinson's disease

Mesh:

Substances:

Year:  2014        PMID: 25219466      PMCID: PMC4268347          DOI: 10.1016/j.neurobiolaging.2014.07.034

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  42 in total

1.  Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.

Authors:  Kang-Woo Lee; Walter Chen; Eunsung Junn; Joo-Young Im; Hilary Grosso; Patricia K Sonsalla; Xuyan Feng; Neelanjana Ray; Jose R Fernandez; Yang Chao; Eliezer Masliah; Michael Voronkov; Steven P Braithwaite; Jeffry B Stock; M Maral Mouradian
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

2.  Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade.

Authors:  Xiaoming Hu; Zhongfang Weng; Charleen T Chu; Lili Zhang; Guodong Cao; Yanqin Gao; Armando Signore; Jianhui Zhu; Teresa Hastings; J Timothy Greenamyre; Jun Chen
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

3.  Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.

Authors:  Eun-Jung Lee; Moon-Sook Woo; Pyong-Gon Moon; Moon-Chang Baek; In-Young Choi; Won-Ki Kim; Eunsung Junn; Hee-Sun Kim
Journal:  J Immunol       Date:  2010-05-28       Impact factor: 5.422

4.  Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.

Authors:  Seonghan Kim; Seo-Hyun Cho; Ka Young Kim; Ki Young Shin; Hye-Sun Kim; Cheol-Hyoung Park; Keun-A Chang; Sang Hyung Lee; Daeho Cho; Yoo-Hun Suh
Journal:  J Neurochem       Date:  2009-03-30       Impact factor: 5.372

5.  Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils.

Authors:  H Wilms; P Rosenstiel; M Romero-Ramos; A Arlt; H Schäfer; D Seegert; P J Kahle; S Odoy; J H Claasen; C Holzknecht; L O Brandenburg; G Deuschl; S Schreiber; D Kirik; R Lucius
Journal:  Int J Immunopathol Pharmacol       Date:  2009 Oct-Dec       Impact factor: 3.219

6.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Michael A Nalls; Vincent Plagnol; Dena G Hernandez; Manu Sharma; Una-Marie Sheerin; Mohamad Saad; J Simón-Sánchez; Claudia Schulte; Suzanne Lesage; Sigurlaug Sveinbjörnsdóttir; Kári Stefánsson; Maria Martinez; John Hardy; Peter Heutink; Alexis Brice; Thomas Gasser; Andrew B Singleton; Nicholas W Wood
Journal:  Lancet       Date:  2011-02-01       Impact factor: 79.321

7.  Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line.

Authors:  Lydia Alvarez-Erviti; Yvonne Couch; Jill Richardson; J Mark Cooper; Matthew J A Wood
Journal:  Neurosci Res       Date:  2011-01-19       Impact factor: 3.304

8.  Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.

Authors:  Taye H Hamza; Cyrus P Zabetian; Albert Tenesa; Alain Laederach; Jennifer Montimurro; Dora Yearout; Denise M Kay; Kimberly F Doheny; Justin Paschall; Elizabeth Pugh; Victoria I Kusel; Randall Collura; John Roberts; Alida Griffith; Ali Samii; William K Scott; John Nutt; Stewart A Factor; Haydeh Payami
Journal:  Nat Genet       Date:  2010-08-15       Impact factor: 38.330

9.  Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.

Authors:  Kang-Woo Lee; Xin Zhao; Joo-Young Im; Hilary Grosso; Won Hee Jang; Teresa W Chan; Patricia K Sonsalla; Dwight C German; Hidenori Ichijo; Eunsung Junn; M Maral Mouradian
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

10.  Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.

Authors:  Vanesa Sanchez-Guajardo; Fabia Febbraro; Deniz Kirik; Marina Romero-Ramos
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more
  8 in total

Review 1.  Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders.

Authors:  So Yeong Cheon; Kyoung Joo Cho
Journal:  J Mol Med (Berl)       Date:  2019-01-07       Impact factor: 4.599

2.  Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice.

Authors:  Jie Zhang; Eun S Park; Hye-Jin Park; Run Yan; Magda Grudniewska; Xiaopei Zhang; Stephanie Oh; Xue Yang; Jean Baum; M Maral Mouradian
Journal:  Neurobiol Aging       Date:  2019-09-25       Impact factor: 4.673

3.  Genetic Pathways Involved in the Pathogenesis of Parkinson's Disease.

Authors:  Konstantina Skolariki; Marios Diamantopoulos; Panayiotis Vlamos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain.

Authors:  Jie Zhang; Mengyuan Zhao; Run Yan; Jun Liu; Santhosh Maddila; Eunsung Junn; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2021-10-25       Impact factor: 6.088

Review 5.  Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention.

Authors:  Sara A Ferreira; Marina Romero-Ramos
Journal:  Front Cell Neurosci       Date:  2018-08-06       Impact factor: 5.505

6.  Ginsenoside Rg1 protects against H2O2‑induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro.

Authors:  Tan-Zhen Xu; Xiao-Yan Shen; Ling-Ling Sun; Ya-Li Chen; Bi-Qiong Zhang; Da-Ke Huang; Wei-Zu Li
Journal:  Int J Mol Med       Date:  2018-11-30       Impact factor: 4.101

7.  Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in Mice.

Authors:  Jie Zhang; Hilary Grosso Jasutkar; Run Yan; Jong-Min Woo; Kang-Woo Lee; Joo-Young Im; Eunsung Junn; Siiri E Iismaa; M Maral Mouradian
Journal:  Neuroscience       Date:  2020-06-02       Impact factor: 3.590

Review 8.  Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions.

Authors:  Veronika Obsilova; Karolina Honzejkova; Tomas Obsil
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.